Data / Form D filings / Impact Proteomics, LLC
Impact Proteomics, LLC: Form D filings
Impact Proteomics, LLC, a biotechnology company in Pittsburgh, PA, filed 2 Form D notices with the SEC between 2020 and 2024. The latest, on August 14, 2024, reports $50,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1406 BROWNING ROAD, Pittsburgh, PA, 15206
- Phone
- (512) 815-2067
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Pennsylvania
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1804332
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | New notice | $1,000,000 | $50,000 | $950,000 | 1 | Aug 6, 2024 | sec.gov |
| Feb 21, 2020 | New notice | $300,000 | $200,000 | $100,000 | 2 | Feb 7, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan Minden | Executive Officer, Director, Promoter | |
| Jeffrey Whitmore | Executive Officer, Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Aug 12, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Impact Proteomics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.